|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 6.580 USD | +3.30% |
|
+58.94% | +20.34% |
| 10-26 | Bolt Biotherapeutics, Inc., Prana Therapies, Inc. - M&A Call | |
| 10-23 | Bolt Biotherapeutics, Inc. Announces Appointment of Sheila Gujrathi, M.D. as Chief Strategy Officer and Director | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.30% | +58.94% | +90.17% | +63.68% | +20.34% | +15.03% | -65.37% | -97.45% | - | 12.68M | |
| +0.65% | -3.36% | -11.99% | +15.75% | +57.11% | +36.98% | +60.50% | +6.07% | - | 64.14B | |
| +1.31% | +2.99% | -4.90% | +4.02% | +12.56% | +12.59% | +84.45% | +211.63% | +5,662.86% | 55.53B | |
| +1.48% | +1.50% | +9.18% | +10.93% | +18.56% | +12.73% | +104.69% | -15.05% | +241.33% | 53.03B | |
| +2.76% | +0.87% | +2.98% | +14.86% | +23.79% | +27.92% | +55.07% | +8.50% | +288.80% | 45.99B | |
| +2.00% | -3.39% | +1.73% | +12.98% | +22.89% | +17.83% | +119.04% | +2.41% | +1,015.51% | 42.45B | |
| +1.34% | -2.86% | -6.45% | +2.64% | +136.94% | +224.43% | +914.08% | +534.35% | - | 40.45B | |
| +0.64% | -3.95% | +6.45% | +6.99% | +10.10% | +11.15% | +45.57% | +7.13% | +158.47% | 32.25B | |
| -2.24% | +42.58% | +63.31% | +102.68% | +86.68% | +103.55% | +90.06% | +31.21% | +238.46% | 34.47B | |
| -2.72% | -0.44% | -15.78% | +14.42% | +43.32% | +23.18% | -10.77% | -61.94% | - | 24.23B | |
| +1.07% | -3.61% | -11.19% | -4.82% | -7.57% | -16.22% | -3.52% | -69.02% | - | 22.1B | |
| +2.13% | +3.13% | -17.58% | -6.87% | -44.28% | -41.33% | +306.11% | +227.75% | +616.25% | 21.18B | |
| +2.80% | +4.56% | +12.46% | +21.32% | +23.33% | +19.32% | +176.76% | +215.27% | +2,297.65% | 19.38B | |
| +4.22% | +8.44% | +26.95% | +55.55% | +87.48% | +99.00% | +116.69% | -14.77% | +392.08% | 17.85B | |
| +0.32% | +3.92% | +13.54% | +26.05% | +38.65% | +42.77% | +85.15% | -15.13% | +109.04% | 16.69B | |
| +1.42% | +2.63% | +13.55% | +17.29% | +51.22% | +65.39% | +228.12% | +204.60% | +509.19% | 16.42B | |
| +1.50% | +4.46% | +8.48% | -1.92% | - | - | - | - | - | 16.39B | |
| +0.84% | +2.13% | +3.90% | +7.62% | +183.22% | +166.23% | +345.61% | +1,427.61% | +795.27% | 15.33B | |
| +17.04% | +15.61% | +21.98% | +18.82% | +17.53% | +20.50% | -8.99% | -25.23% | +166.63% | 16.04B | |
| +0.97% | -2.23% | -7.44% | -12.02% | +11.63% | +3.84% | +435.21% | - | - | 13.21B | |
| Average | +2.09% | +6.65% | +9.97% | +18.50% | +41.76% | +44.47% | +162.02% | +143.22% | +960.89% | 28.36B | |
| Weighted average by Cap. | +1.60% | +3.56% | +4.25% | +16.52% | +41.67% | +45.35% | +165.19% | +120.99% | +1,258.56% |
- Stock Market
- Stocks
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
